Vasa Denticity's growth slowed to 13% and PAT declined, citing tender business cuts, BOE-BOD shift, and private label stock-outs.

Management targets 25-30% revenue growth, high 20s% gross margin, and mid-teens% EBITDA in 2-3 years.

Inventory is elevated; IDS Denmed acquisition pending.